Woods Keith, Chief Operating Officer of Scholar Rock Holding Corp ($SRRK), sold shares on the open market once in the last year, totaling about $715 thousand. His most recent sale occurred on January 13, 2026. These sales rank 5,689th among over 11,600 insiders in our database, where the average is $8.6 million across 6.4 transactions per person. Keith made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 20, 2026 | Neurogene Inc. | $NGNE | Woods Keith | Director | A | Non-Qualified Stock Option (right to buy) | 12050 | $0.00 | 12,050.0000 | 21,168,431 | 9999.99% | 0.06% |
| Feb. 9, 2026 | Scholar Rock Holding Corp | $SRRK | Woods Keith | Chief Operating Officer | A | Common Stock | 47021 | $0.00 | 630,275.0000 | 114,701,154 | 8.06% | 0.04% |
| Jan. 13, 2026 | Scholar Rock Holding Corp | $SRRK | Woods Keith | Chief Operating Officer | S | Common Stock | 16746 | $42.70 | 583,254.0000 | 114,701,154 | 2.79% | 0.01% |
| June 30, 2025 | TScan Therapeutics, Inc. | $TCRX | Woods Keith | Not found | A | Stock Option (Right to Buy) | 67000 | $0.00 | 67,000.0000 | 111,990,417 | 9999.99% | 0.06% |
| June 9, 2025 | X4 Pharmaceuticals, Inc | $XFOR | Woods Keith | Director | A | Common Stock | 1500 | $0.00 | 6,000.0000 | 201,062,211 | 33.33% | 0.00% |
| May 2, 2025 | Scholar Rock Holding Corp | $SRRK | Woods Keith | Chief Operating Officer | A | Stock Option (Right to Buy) | 110067 | $0.00 | 110,067.0000 | 111,838,272 | 9999.99% | 0.10% |
| April 27, 2025 | Scholar Rock Holding Corp | $SRRK | Woods Keith | Chief Operating Officer | A | Common Stock | 500000 | $0.00 | 600,000.0000 | 111,838,272 | 500.00% | 0.45% |
| April 27, 2025 | Scholar Rock Holding Corp | $SRRK | Woods Keith | Chief Operating Officer | A | Common Stock | 100000 | $0.00 | 100,000.0000 | 111,838,272 | 9999.99% | 0.09% |
| June 13, 2024 | ROCKET PHARMACEUTICALS, INC. | $RCKT | Woods Keith | Not found | A | Stock Option (Right to Buy) | 23944 | $0.00 | 23,944.0000 | 84,009,004 | 9999.99% | 0.03% |
| June 12, 2024 | TScan Therapeutics, Inc. | $TCRX | Woods Keith | Not found | A | Stock Option (Right to Buy) | 47500 | $0.00 | 47,500.0000 | 65,599,858 | 9999.99% | 0.07% |
| June 10, 2024 | X4 Pharmaceuticals, Inc | $XFOR | Woods Keith | Director | A | Common Stock | 45000 | $0.00 | 135,000.0000 | 177,812,480 | 50.00% | 0.03% |
| Oct. 16, 2023 | X4 Pharmaceuticals, Inc | $XFOR | Woods Keith | Director | A | Common Stock | 90000 | $0.00 | 90,000.0000 | 63,525,845 | 9999.99% | 0.14% |